Immunotherapeutic Agents

Therapy Advancements and Biomarker Identifications Leading to Improved Ability to Predict and Enhance Responses To Immunotherapeutic Agents In Non–Small Cell Lung Cancer (NSCLC)

Oct 17, 2019 | Biomarker, Biomarker Lung Cancer, Immune Checkpoint Inhibitors, Immunotherapeutic Agents, Non-Small Cell Lung Cancer

Targeted therapy advancements and the identification of emerging biomarkers of response to treatment have led to an improved ability to predict and enhance responses to immunotherapeutic agents in non–small cell lung cancer (NSCLC). Available agents that have...